530.43
price down icon0.00%   -0.065
 
loading
Idexx Laboratories Inc stock is traded at $530.43, with a volume of 91,661. It is down -0.00% in the last 24 hours and up +5.77% over the past month. Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
See More
Previous Close:
$530.50
Open:
$531.69
24h Volume:
91,661
Relative Volume:
0.12
Market Cap:
$42.30B
Revenue:
$3.93B
Net Income/Loss:
$894.97M
P/E Ratio:
49.02
EPS:
10.82
Net Cash Flow:
$837.70M
1W Performance:
+2.05%
1M Performance:
+5.77%
6M Performance:
+28.26%
1Y Performance:
+8.03%
1-Day Range:
Value
$527.66
$533.32
1-Week Range:
Value
$517.14
$533.32
52-Week Range:
Value
$356.14
$533.32

Idexx Laboratories Inc Stock (IDXX) Company Profile

Name
Name
Idexx Laboratories Inc
Name
Phone
(207) 556-0300
Name
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Name
Employee
11,000
Name
Twitter
@idexx
Name
Next Earnings Date
2025-02-03
Name
Latest SEC Filings
Name
IDXX's Discussions on Twitter

Compare IDXX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
530.24 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
400.45 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
197.75 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
A
Agilent Technologies Inc
117.85 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
156.63 27.64B 15.50B 1.33B 2.16B 7.34

Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-02-24 Initiated Leerink Partners Outperform
Jul-25-24 Initiated BTIG Research Buy
Jan-30-24 Downgrade Piper Sandler Overweight → Neutral
Dec-07-23 Initiated Exane BNP Paribas Outperform
Dec-04-23 Upgrade Cleveland Research Neutral → Buy
Aug-02-23 Downgrade Atlantic Equities Overweight → Neutral
Jul-25-22 Downgrade Stifel Buy → Hold
Jul-21-22 Upgrade Goldman Neutral → Buy
Jul-12-22 Initiated Piper Sandler Overweight
May-05-22 Downgrade BofA Securities Buy → Neutral
Feb-08-22 Initiated Atlantic Equities Overweight
Nov-18-21 Initiated Morgan Stanley Overweight
Aug-05-21 Resumed Credit Suisse Outperform
Jul-12-21 Downgrade Guggenheim Buy → Neutral
Feb-17-21 Initiated Barclays Overweight
Sep-09-19 Initiated Goldman Neutral
May-23-19 Initiated Guggenheim Buy
Nov-02-18 Reiterated BofA/Merrill Buy
May-07-18 Reiterated Stifel Buy
Jan-16-18 Initiated Piper Jaffray Overweight
Aug-23-17 Upgrade BofA/Merrill Neutral → Buy
Jul-28-17 Upgrade CL King Neutral → Buy
Feb-03-17 Downgrade Feltl & Co. Hold → Sell
Sep-29-16 Resumed BofA/Merrill Neutral
Aug-16-16 Reiterated Stifel Buy
Aug-03-16 Upgrade Northcoast Sell → Neutral
Jul-20-16 Reiterated Canaccord Genuity Buy
Apr-19-16 Reiterated Canaccord Genuity Buy
Apr-01-16 Initiated CL King Neutral
Mar-21-16 Reiterated Stifel Buy
Feb-04-16 Initiated Credit Suisse Outperform
Oct-29-15 Reiterated Stifel Buy
Aug-28-15 Downgrade Raymond James Outperform → Mkt Perform
Aug-13-15 Reiterated Stifel Buy
Jul-23-15 Reiterated Canaccord Genuity Buy
View All

Idexx Laboratories Inc Stock (IDXX) Latest News

pulisher
Jun 17, 2025

IDEXX Laboratories (IDXX) Price Target Hiked to $580 at Leerink Partners - Insider Monkey

Jun 17, 2025
pulisher
Jun 16, 2025

12 Best Healthcare Stocks to Buy Now - Insider Monkey

Jun 16, 2025
pulisher
Jun 11, 2025

IDEXX Laboratories Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga

Jun 11, 2025
pulisher
Jun 11, 2025

IDEXX Laboratories (IDXX) Sees Price Target Raised by Leerink Pa - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Three Lawmakers Bought This Biotech Stock Before Supporting A Bill That Could Boost Its Value: It's Now Up 44% - Benzinga

Jun 11, 2025
pulisher
Jun 11, 2025

Is IDEXX Laboratories Stock Outperforming The Dow? - Barchart.com

Jun 11, 2025
pulisher
Jun 11, 2025

Is IDEXX Laboratories Stock Outperforming the Dow? - The Globe and Mail

Jun 11, 2025
pulisher
Jun 11, 2025

Leerink Partners Adjusts IDEXX Laboratories Price Target to $580 From $515 - MarketScreener

Jun 11, 2025
pulisher
Jun 11, 2025

Kalkine : IDEXX Laboratories Performance Within S&P 500 Index Framework - Kalkine Media

Jun 11, 2025
pulisher
Jun 10, 2025

IDEXX Labs $IDXX Sees Surge in Political Buys: 3 Politicians on Agriculture Committees Invest – Crypto Market Eyes Regulatory Impact - Blockchain News

Jun 10, 2025
pulisher
Jun 10, 2025

IDEXX Catalyst Cortisol Rapid Canine Dx - Precedence Research

Jun 10, 2025
pulisher
Jun 07, 2025

Amazon Delivery Robots Could Haunt Your Front Porch - Yahoo! Autos

Jun 07, 2025
pulisher
Jun 06, 2025

Jim Cramer on IDEXX Laboratories, Inc. (IDXX): “I Just Can’t Get My Arms Around It” - MSN

Jun 06, 2025
pulisher
Jun 05, 2025

Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders - StreetInsider

Jun 05, 2025
pulisher
Jun 05, 2025

IDEXX Unveils Game-Changing Dog Disease Test: Breakthrough for Detecting Life-Threatening Addison's Disease - Stock Titan

Jun 05, 2025
pulisher
Jun 02, 2025

IDEXX Laboratories (IDXX) Stock Analysis: A Look at Its Robust 59.33% ROE Amidst Market Challenges - DirectorsTalk Interviews

Jun 02, 2025
pulisher
Jun 01, 2025

Jim Cramer’s Thoughts on These 10 Stocks - Insider Monkey

Jun 01, 2025
pulisher
Jun 01, 2025

IDEXX Laboratories (NASDAQ:IDXX) Stock Rating Lowered by Wall Street Zen - Defense World

Jun 01, 2025
pulisher
May 29, 2025

Companion Animal Diagnostics Market Is Booming WorldwideIDEXX Laboratories, Heska Corporation - openPR.com

May 29, 2025
pulisher
May 28, 2025

Transcript : IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference 2025, May-28-2025 10 - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

IDEXX Laboratories To Present At Stifel Jaws & Paws Conference; Webcast At 10:55 AM ET - Nasdaq

May 28, 2025
pulisher
May 28, 2025

IDEXX Laboratories Stock: Analyst Estimates & Ratings - MSN

May 28, 2025
pulisher
May 26, 2025

IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - simplywall.st

May 26, 2025
pulisher
May 23, 2025

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World

May 23, 2025
pulisher
May 21, 2025

IDEXX Lab jumps after Q1 beat and guidance raise - MSN

May 21, 2025
pulisher
May 21, 2025

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today - Benzinga

May 21, 2025
pulisher
May 20, 2025

IDEXX Laboratories (NASDAQ:IDXX) Given New $510.00 Price Target at Stifel Nicolaus - Defense World

May 20, 2025
pulisher
May 19, 2025

IDEXX Laboratories (IDXX) Target Price Raised by Stifel to $510 | IDXX Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

If You Invested $1000 in Idexx Laboratories a Decade Ago, This is How Much It'd Be Worth Now - Yahoo Finance

May 19, 2025
pulisher
May 19, 2025

Idexx Laboratories (IDXX) Price Target Increased by Stifel Analy - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Stifel Adjusts Price Target on IDEXX Laboratories to $510 From $460, Maintains Hold Rating - marketscreener.com

May 19, 2025
pulisher
May 15, 2025

5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil - TradingView

May 15, 2025
pulisher
May 14, 2025

IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits (NASDAQ:IDXX) - Seeking Alpha

May 14, 2025
pulisher
May 14, 2025

Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year? - Yahoo Finance

May 14, 2025
pulisher
May 14, 2025

Director Cashes In: Idexx Laboratories Stock Sale Revealed - TipRanks

May 14, 2025
pulisher
May 13, 2025

IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day | IDXX Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day - Business Wire

May 13, 2025
pulisher
May 12, 2025

BNP Paribas Exane Adjusts Price Target on IDEXX Laboratories to $577 From $566, Maintains Outperform Rating - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

IDEXX Laboratories (NASDAQ:IDXX) Upgraded at StockNews.com - Defense World

May 12, 2025
pulisher
May 11, 2025

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable - simplywall.st

May 11, 2025
pulisher
May 10, 2025

Idexx outlines 2025 growth with 6-9% organic revenue target amid innovation launches - MSN

May 10, 2025
pulisher
May 09, 2025

IDEXX Laboratories (IDXX) Announces Key Amendments to Corporate Structure - GuruFocus

May 09, 2025
pulisher
May 09, 2025

IDEXX Laboratories Updates Corporate Governance Structure - TipRanks

May 09, 2025
pulisher
May 08, 2025

Here’s Why Baron Focused Growth Fund Invested in IDEXX Laboratories (IDXX) - Insider Monkey

May 08, 2025
pulisher
May 06, 2025

IDEXX Laboratories (NASDAQ:IDXX) Price Target Raised to $558.00 at Morgan Stanley - Defense World

May 06, 2025
pulisher
May 06, 2025

Rep. April McClain Delaney Buys IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock - Defense World

May 06, 2025
pulisher
May 05, 2025

IDEXX Laboratories (IDXX) Target Price Raised by Morgan Stanley | IDXX Stock News - GuruFocus

May 05, 2025

Idexx Laboratories Inc Stock (IDXX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Idexx Laboratories Inc Stock (IDXX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
SZOSTAK M ANNE
Director
May 21 '25
Option Exercise
160.28
1,046
167,653
1,308
SZOSTAK M ANNE
Director
May 21 '25
Sale
512.34
1,260
645,545
1,801
SZOSTAK M ANNE
Director
May 21 '25
Sale
513.74
1,046
537,372
262
diagnostics_research A
$117.75
price up icon 0.09%
diagnostics_research IQV
$156.56
price down icon 1.34%
diagnostics_research MTD
$1,174.78
price down icon 0.69%
$168.16
price down icon 1.99%
diagnostics_research LH
$258.19
price down icon 1.68%
Cap:     |  Volume (24h):